Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Indivior PLC (NASDAQ:INDV) shares surged 14.5% in pre-market trading after reporting better-than-expected Q2 earnings and announcing a $100 million share repurchase program. Other notable pre-market movers include Psyence Biomedical Ltd. (NASDAQ:PBM), BloomZ Inc. (NASDAQ:BLMZ), and 2U, Inc. (NASDAQ:TWOU), among others.

July 25, 2024 | 10:36 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Edwards Lifesciences Corporation shares fell 22% in pre-market trading after reporting worse-than-expected Q2 sales and issuing weak Q3 guidance.
The poor sales performance and weak guidance are strong negative catalysts for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Ford Motor Company shares fell 13% in pre-market trading following a second-quarter earnings miss.
The earnings miss is a negative catalyst, likely leading to a short-term decline in the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
2U, Inc. shares fell 67.7% in pre-market trading after announcing a strategic agreement with debtholders to eliminate half of its debt and infuse $110 million in new capital.
The significant drop in share price is likely due to investor concerns over the company's financial restructuring and its implications.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
BloomZ Inc. shares gained 81.2% in pre-market trading after a significant drop the previous day. The company recently priced its IPO at $4.30 per share.
The sharp rebound in share price following a significant drop suggests high volatility and investor interest post-IPO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Indivior PLC shares rose 14.5% in pre-market trading after the company reported better-than-expected Q2 earnings and announced a $100 million share repurchase program.
The significant earnings beat and the announcement of a substantial share repurchase program are strong positive catalysts for the stock.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Psyence Biomedical Ltd. shares surged 157.4% in pre-market trading after announcing the export of nature-derived psilocybin to Australia and an upcoming trial.
The announcement of a significant milestone in the company's product development and upcoming trial is a strong positive catalyst.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80